Literature DB >> 9684748

Evidence that microsomal triglyceride transfer protein is limiting in the production of apolipoprotein B-containing lipoproteins in hepatic cells.

H Jamil1, C H Chu, J K Dickson, Y Chen, M Yan, S A Biller, R E Gregg, J R Wetterau, D A Gordon.   

Abstract

The microsomal triglyceride transfer protein (MTP) is a heterodimeric lipid transfer protein that is required for the assembly and secretion of apolipoprotein B (apoB)-containing lipoproteins. A key unresolved question is whether the MTP-mediated step is rate limiting. To address this, a unique experimental strategy was used that allowed the in situ modulation and measurement of MTP triglyceride transfer activity. In order to accomplish this, an irreversible photoaffinity inhibitor, BMS-192951, was designed and synthesized. When incubated with purified MTP and irradiated with UV light at 360 nm, BMS-192951 inhibits triglyceride transfer by covalently binding to the protein. HepG2 cells were treated with either increasing concentrations of BMS-192951 (0-15 microM) with 5 min of ultraviolet irradiation, or 3.0 microM BMS-192951 with various lengths (0-15 min) of ultraviolet irradiation. Microsomal extracts were prepared exhaustively dialyzed to remove unbound inhibitor, and assayed for MTP-mediated triglyceride transfer activity. BMS-192951 was shown to reduce MTP activity in both a dose- and UV exposure time-dependent fashion. Measurement of apoB concentration in the media showed that apoB secretion was reduced in proportion to the in situ inhibition of MTP activity, while no change was observed in apoA-I secretion. Experiments performed in McArdle RH-7777 rat hepatoma cells and primary rat hepatocytes gave nearly identical results; the decrease in apoB secretion was proportional to the decrease in MTP activity. These results indicate that MTP-mediated lipid transfer is limiting in the assembly and secretion of apoB-containing lipoproteins in hepatic cells under the conditions tested.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9684748

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  11 in total

1.  Haplotype-based identification of a microsomal transfer protein marker associated with the human lifespan.

Authors:  Bard J Geesaman; Erica Benson; Stephanie J Brewster; Louis M Kunkel; Hélène Blanché; Gilles Thomas; Thomas T Perls; Mark J Daly; Annibale A Puca
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-13       Impact factor: 11.205

2.  Polymorphisms of microsomal triglyceride transfer protein in different hepatitis B virus-infected patients.

Authors:  Zhi-Tao Yang; Xin-Xin Zhang; Xiao-Fei Kong; Dong-Hua Zhang; Shen-Ying Zhang; Jie-Hong Jiang; Qi-Ming Gong; Gen-Di Jin; Zhi-Meng Lu
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

Review 3.  Insights from human congenital disorders of intestinal lipid metabolism.

Authors:  Emile Levy
Journal:  J Lipid Res       Date:  2014-11-11       Impact factor: 5.922

4.  Identification and characterization of dual inhibitors for phospholipid transfer protein and microsomal triglyceride transfer protein.

Authors:  Yi Luo; Lorraine Shelly; Thomas Sand; George Chang; Xian-Cheng Jiang
Journal:  J Pharmacol Exp Ther       Date:  2010-08-30       Impact factor: 4.030

5.  No association between microsomal triglyceride transfer protein (MTP) haplotype and longevity in humans.

Authors:  Almut Nebel; Peter J P Croucher; Rieke Stiegeler; Susanna Nikolaus; Michael Krawczak; Stefan Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-23       Impact factor: 11.205

6.  A role of apolipoprotein D in triglyceride metabolism.

Authors:  German Perdomo; Dae Hyun Kim; Ting Zhang; Shen Qu; Elizabeth A Thomas; Frederico G S Toledo; Sandra Slusher; Yong Fan; David E Kelley; H Henry Dong
Journal:  J Lipid Res       Date:  2010-02-02       Impact factor: 5.922

Review 7.  FoxO1 integrates insulin signaling to VLDL production.

Authors:  Adama Kamagate; H Henry Dong
Journal:  Cell Cycle       Date:  2008-10-27       Impact factor: 4.534

Review 8.  Cholesterol absorption inhibitors for the treatment of hypercholesterolaemia.

Authors:  Thomas Sudhop; Klaus von Bergmann
Journal:  Drugs       Date:  2002       Impact factor: 9.546

9.  MTP regulated by an alternate promoter is essential for NKT cell development.

Authors:  Stephanie K Dougan; Paul Rava; M Mahmood Hussain; Richard S Blumberg
Journal:  J Exp Med       Date:  2007-02-20       Impact factor: 14.307

10.  Artemisia Iwayomogi Extract Attenuates High-Fat Diet-Induced Hypertriglyceridemia in Mice: Potential Involvement of the Adiponectin-AMPK Pathway and Very Low Density Lipoprotein Assembly in the Liver.

Authors:  Jinhui Lee; Vikram P Narayan; Eun Young Hong; Wan Kyunn Whang; Taesun Park
Journal:  Int J Mol Sci       Date:  2017-08-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.